Margaux Dastor

Margaux Dastor combines a strong scientific background in gene therapy research with a passion for translating innovative technologies into impactful business opportunities.

She earned her Doctor of Science degree from ETH Zürich, where she specialized in synthetic biology, gene expression engineering, and viral vector applications for gene therapy.

Her career includes research roles at ETH Zürich, Harvard Medical School, Dana-Farber Cancer Institute, Vector BioPharma, and Novartis, where she contributed to the development of advanced cell engineering and viral vector technologies.

In addition to her scientific expertise, Margaux has gained experience in project leadership, ecosystem building, and strategic outreach through her work with Nucleate Switzerland and biotech innovation programs.

At NewBiologix, she supports business development activities, connecting scientific innovation with customer and partner needs in the rapidly evolving gene therapy sector.